Project Details
Description
EFFICACY AND SAFETY OF ERAXIS/ECALTA (ANIDULAFUNGIN) COMPARED TO CANCIDAS (CASPOFUNGIN) IN NEUTROPENIC PATIENTS WITH INVASIVE CANDIDA INFECTION
| Status | Finished |
|---|---|
| Effective start/end date | 3/15/10 → 6/21/12 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.